The most important number in Evernorth's warrant filing was never printed. The document disclosed $132.2 million. It disclosed up to 11.5 million shares. Divide the first by the second and you land on $11.495. Round it and you have $11.50 โ the standard SPAC warrant strike, unchanged since the 2020 shell-company mania. That arithmetic reconciliation is the entire story, and almost nobody in the coverage bothered to perform it. Once you know the strike, you know the trigger. This registration only matters if XRPN trades above $11.50. Below that level, the SEC's signature is administrative theater. Above it, you have a mechanical wealth transfer from shareholders to warrant holders, priced at a fixed number while the market floats around it. Everything else โ the "registration effective" headline, the "up to" hedge, the "general corporate purposes" boilerplate โ is scaffolding erected around a single ratio. Entropy wins. Always check the fees.
To understand why that ratio matters, you have to separate what happened from what the headline implies. Evernorth, trading on Nasdaq under XRPN, is a digital asset treasury company โ a DAT, in the current shorthand โ built around XRP. It reached the public market in 2025 through a SPAC merger, reportedly with Armada Acquisition Corp II. That structure is the source of the warrants in question. A SPAC does not merely sell shares; it sells units, each containing a fraction of a share and a warrant. The warrant is a long-dated call option the company issued to itself as currency, struck at a standard $11.50, exercisable for one share. For most of the SPAC's life, those warrants are illiquid instruments. They cannot be freely exercised and resold until the company files a registration statement covering the underlying shares โ and until the SEC declares that statement effective.
That is precisely the event this week. The registration became effective. This is not a product launch, not a partnership, not a treasury purchase. It is an administrative milestone in the securities process. It changes the legal liquidity state of a security; it changes nothing about the company's operations, its XRP holdings, or its revenue. I have watched this exact headline recycled across dozens of de-SPACs, and the market reflex is almost always wrong: it reads "registration effective" as forward progress and bids the stock, when the mechanical consequence is the opposite โ it unlocks supply. The registration does not create value. It creates sellers.
Here is where the arithmetic becomes forensic. $132.2 million divided by 11.5 million shares is $11.495. Multiply 11.5 million by $11.50 and you get $132.25 million. The two disclosed numbers are not independent; they are the same number expressed two ways. That tells you these are standard SPAC warrants โ one warrant, one share, $11.50 cash exercise โ and not some newly minted incentive instrument. The net proceeds, the filing notes, go to "general corporate purposes." That phrase confirms cash exercise rather than cashless exercise: real dollars will enter the company's account, not just newly printed shares.
The qualifier "up to" is the most information-dense word in the entire document. It means 11.5 million is a ceiling, not a commitment. Actual exercise depends entirely on holder behavior and the prevailing share price. Any analyst who multiplies 11.5 million by the current price and calls it "dilution" has skipped the only step that matters.
The dilution that matters is not the share count. It is the spread between the fixed $11.50 strike and the floating market price. This is the part the naive framing misses. A warrant struck at $11.50, when the stock trades at $30, delivers a $30 share for $11.50 โ an $18.50 transfer per warrant, per share, from existing holders to warrant holders. That is not dilution measured in share count; it is dilution measured in value, and it scales with how far in the money the warrant sits. When the stock hovers at $12, the transfer is trivial and most holders wait. When it trades at $40, the transfer is enormous and every holder exercises at once. The "up to 11.5 million shares" framing therefore understates the economic damage precisely when the stock is high, and overstates the practical impact precisely when the stock is near or below the strike โ where nothing happens at all. The number is not a constant. It is a function of price, and the filing refuses to say which regime we are in.
The missing datum is the denominator. The filing discloses no total share count. That is the critical gap. Without it, no one can compute the actual dilution percentage, and no one can compute the mNAV โ the market-to-net-asset-value ratio โ that governs the entire DAT thesis. Run a sensitivity anyway: 11.5 million new shares against a base of 90 million is roughly 12.8% dilution; against 120 million, roughly 9.6%; against 150 million, roughly 7.7%. A spread that wide is not analysis; it is a confession that the denominator is unknown. A registration statement that lets warrant holders sell while withholding the share count answers the question it wants asked and buries the one that matters.
Composition determines selling intensity, and the filing says nothing about it. SPAC sponsor warrants โ the "promote" โ are typically acquired for near-zero cost. For a sponsor holding them, any price above $11.50 is nearly pure profit, and the rational move is to exercise and dump immediately. PIPE warrants, by contrast, are usually acquired closer to market and carry a gentler incentive. The mix is everything. A float dominated by sponsor paper produces a violent, immediate overhang the week the registration goes effective. A float dominated by PIPE paper produces a slow bleed. We are told neither.
There is a second, quieter mechanism worth flagging. Standard SPAC warrants frequently carry a forced-redemption clause: once the stock trades above a threshold โ commonly $18 โ for a set number of consecutive sessions, the company can call the warrants and compel exercise. If Evernorth's warrants carry that trigger, the registration is not merely an unlock; it is the runway to a forced call, and the effective date becomes a countdown rather than a formality. I would treat the absence of any redemption discussion in the coverage as a gap, not an assurance. Registration statements also carry shelf lives โ typically measured in tens of days before re-registration is required โ which introduces a hidden urgency that never appears in the prose but is legible in the timing.
Then there is the hedging flow. Market makers who are short warrant exposure hedge by shorting the underlying stock ahead of exercise. That flow is persistent, mechanical, and price-insensitive. It does not care about the XRP narrative. It is the same dynamic that suppressed dozens of de-SPAC stocks during their unlock windows, and it operates whether or not anyone is watching.
Step back to the structure. A DAT company's valuation is not anchored to cash flow; it is anchored to the underlying asset. The classic flywheel runs: trade above net asset value (mNAV > 1) โ issue equity at a premium โ use proceeds to buy more of the underlying โ per-share coin count rises โ the premium is "justified" โ issue again. It works beautifully while the premium holds. Its fatal flaw is asymmetric: the moment mNAV drops below 1, the same machinery runs in reverse, and every issuance becomes value destruction rather than accretion.
Warrant exercise is one rotation of that flywheel โ but with a critical twist. The strike is fixed at $11.50. It does not float with mNAV. So the company is selling equity at a hard-coded price regardless of where its premium sits. If XRPN trades at a high multiple to NAV, $11.50 is a deep discount to intrinsic value: the company is handing value to warrant holders instead of raising capital accretively. If it trades near NAV, $11.50 is fair. The fixed strike decouples the financing from the very metric that is supposed to govern it. That is not a bug in the instrument; it is the instrument, and it is why warrant overhangs are so corrosive to premium-priced vehicles.
There is a further layer of leverage. The $11.50 per share raised, if deployed into XRP, does not sit idle โ it amplifies the same beta the company already carries. In a rising XRP tape, that magnifies returns and makes the premium look brilliant. In a falling tape, it magnifies losses and makes the premium look like a rounding error. A treasury vehicle that raises cash at a fixed strike and redeploys it into a single volatile asset is not diversifying risk; it is stacking it, then selling the stack to retail as "exposure."
The $132.2 million, if fully exercised, lands in the company's account with no covenant attached. "General corporate purposes" spans three outcomes with opposite implications: a share buyback below NAV is accretive to remaining holders; an acquisition is neutral-to-uncertain; funding operating expenses is outright destructive because it converts shareholder capital into payroll. Shareholders have no pre-commitment, no vote, no constraint. In my forensic work on FTX's withdrawal engine, the lesson was not that the ledger lied โ it was that the ledger was permitted to lie because no external party had the authority or the data to check it. The same governance vacuum applies here, in miniature: management holds full discretion over the proceeds, and the disclosure gives holders no mechanism to price that discretion.
The real regulatory exposure for a company like this is not on the securities side โ that is settled. It is on the asset side. Holding a large XRP position raises fair-value measurement, impairment treatment, and auditor-opinion questions. If an auditor issues a qualification on crypto-asset valuation, that is a far larger event than any registration statement. The filing is silent.
The reflexive read of this news is bullish โ a process milestone, a step toward "normalization." I think that read is backwards, and it is backwards for a structural reason the market keeps forgetting. Historically, warrant registration effectiveness in the de-SPAC complex is a technical bearish event, because it converts paper into sellable supply held by arbitrageurs whose entire business model is to monetize the strike-to-spot spread. It does not matter how good the XRP story is. The warrants do not read the story.
But the deeper blind spot is elsewhere, and it is the one nobody is pricing. Everyone is staring at 11.5 million shares. Almost no one is staring at the mNAV, and almost no one is staring at the predator circling the entire DAT category: the spot ETF. A physically backed, cheap, transparent XRP ETF is the natural enemy of the DAT wrapper. Why pay a premium for a levered, single-asset, management-discretionary holding company when you can buy the exposure directly at a few basis points? The DAT's only defensible moat is regulatory access and, in some cases, yield strategies on the underlying. The moment a plain-vanilla ETF exists, that moat drains. This is not speculation; it is the exact competitive dynamic that compressed bitcoin treasury premiums once spot bitcoin ETFs launched. 2017 vibes. Proceed with skepticism.
There is also a directional paradox worth flagging. If the $132.2 million is used to buy more XRP, that is mildly constructive for XRP spot โ a small, credible bid. But it is dilutive for XRPN holders. The good news for the asset is the bad news for the wrapper. The two can move in opposite directions on the same headline, and the coverage conflates them. Add a crowded field โ multiple XRP-adjacent treasury vehicles chasing the same premium โ and the mNAV of any single name is squeezed from above by competitors and from below by the ETF. That is a vise, not a moat.
So what should you actually watch? Three numbers, none of which appear in the press release. First, the strike-to-spot spread: whether XRPN sits meaningfully above $11.50 determines whether this registration is a wealth transfer or a dead letter. Second, the mNAV: a premium above 1.5 means the flywheel is still spinning and the dilution is accretive theater; a drop below 1 means the machine has reversed and every share printed destroys value. Third, the audit opinion on the XRP position: the only disclosure that can reprice the asset side. Until those three are visible, any confident call on direction is guesswork dressed as conviction. Impermanent loss is real. Do your math โ including the denominator the filing left blank.